Navigation Links
Leeches Provide Clues Regarding The Prevention Of Heart Disease

Cardiovascular diseases have now become common place owing to the wide scale industrialization and subsequent// change in life style. Time and over again, scientists have been working on ways to prevent or treat heart ailments without surgical intervention. The results of a recent research have recently confirmed that leeches could be used in the treatment of cardiovascular diseases.

The leeches have added to the biomedical interest by showing that it contains an extensive list of new potential molecules that may become useful tools. There has been an increasing tendency to turn towards blood-feeding invertebrates as a source for drugs and lead compounds to treat cardiovascular disease because these animals have evolved highly efficient mechanisms to feed on their hosts by blocking blood coagulation.

Most heart attacks and strokes are associated with a blocked artery and in a majority of the cases; blood clots may cause the blockage of blood vessels supplying the heart, leading to heart disease. Furthermore, people with cardiovascular disease typically have an increased tendency to form blood clots, and a decreased ability to dissolve clots before they can do any damage. Therefore, compounds interrupting the blood coagulation cascade may inhibit thrombus development as well.

The researchers have identified and analyzed peptides and small proteins in the saliva of the medical leech Hirudo medicinalis for their ability to bind to molecules called serine proteases. These molecules have the ability to prevent coagulation or clotting of blood.

Of the nearly 2,000 molecules the researches screened, more than 75 of them interacted specifically with the fixed target and 16 of these binding molecules were isolated and subsequently characterized as new inhibitors that had potential to be used as drugs in treating cardiovascular disease.

Although these newly discovered molecules are a long way from being used to treat cardiovasc ular disease, they do represent several important leads in the search for more effective anticoagulant and fibrinolytic drugs. The research tem has also expressed interest towards screening of different types of leeches and other blood sucking animals for their anti-coagulant potential.

Medindia on chest pain:

Some causes of chest pain require prompt medical attention, such as angina, heart attack, or tearing of the aorta. Other causes of chest pain can be evaluated electively, such as spasm of the esophagus, gallbladder attack, or inflammation of the chest wall.
'"/>




Related medicine news :

1. Leeches help in tissue transfer
2. Drug Spironolactone Provides Renal And Cardioprotection In Diabetic Patients
3. Neurobiology Provides Answers To Block Memory-Related Drug Cravings
4. Reliance Infocomm Tied With Apollo To Provide Telemedicine Services
5. Apollo Hospitals Short-listed to Provide Diagnostics in the UK
6. Reindeer Provide Valuable Insights Into Sleep Disorders
7. London Hospital Provides Specialized Care For Pregnant Women
8. CNIC To Provide Funds To Mount Sinai School
9. Clean Blades To Be Provided To Self-Harmers
10. Breastfeeding Provides Added Protection To Babies
11. Court Orders Private Hospitals To Provide Free Treatment For The Poor
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/24/2017)... ... , ... “Journey to the Light: The Quest for Happiness and Love. . ... to finding herself. “Journey to the Light: The Quest for Happiness and Love. ... writer of newsletters, manuals, and articles, who has recently decided to expand her literary ...
(Date:7/23/2017)... (PRWEB) , ... July 23, 2017 , ... A ... in St. Louis, and led by the Minneapolis Veterans Administration Health Care System overwhelmingly ... of the disease offers very few benefits. , In the cases involved with ...
(Date:7/23/2017)... ... 23, 2017 , ... Technology is making it easier for ... tools are helping patients become more actively involved in their care and maintaining ... survey, released today by the American Hospital Association’s (AHA) Health Forum. , According ...
(Date:7/23/2017)... ... July 23, 2017 , ... Viora Ltd., a ... US Patent No. 9,038,640 by the United States Patent and Trademark Office. The ... combination of Switching, Vacuum, and Cooling mechanisms to further increase the efficacy and ...
(Date:7/21/2017)... ... July 21, 2017 , ... "As a doctor of lung medicine ... catheters available on the market," said an inventor from Center Valley, Pa. "My idea ... the patient." , He developed the patent-pending PLEURAL SAFE-t-STAT CATHETER KIT to offer an ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/10/2017)... , July 10, 2017 The Institute for ... methods, is the recipient of a VITROCELL® inhalation exposure ... International Science Consortium. The device, which is designed to ... expose human lung cells to airborne test materials in ... use the VITROCELL® system for testing combustible tobacco products, ...
(Date:7/5/2017)... 5, 2017 Wolfmet 3D  printed tungsten collimator manufactured by ... and manufacturing combine to progress molecular radiotherapy imaging. ... are unable to accurately quantify the radiation absorbed by those ... the success of this radiotherapy treatment has been available — ... ...
Breaking Medicine Technology: